Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-22-000012
Filing Date
2022-02-09
Accepted
2022-02-09 20:59:08
Documents
1
Period of Report
2022-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 6189
  Complete submission text file 0001735276-22-000012.txt   7710
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510
Business Address
Franchini Indrani Lall (Reporting) CIK: 0001708764 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 22609279